Form 4: 4D Molecular Therapeutics Director, Susannah Gray, Acquires Stock Options

Susannah Gray, a director of 4D Molecular Therapeutics, acquired 22,500 stock options on May 21, 2024, as part of the company's non-employee director compensation program.

Summary

• On May 21, 2024, Susannah Gray, a director of 4D Molecular Therapeutics, acquired 22,500 stock options.
• The options were granted automatically under the company's non-employee director compensation program.
• The exercise price of the stock options is $25.15.
• The options vest in three tranches: 1/3 on May 21, 2025, and then in equal monthly installments until fully vested on May 21, 2027, contingent upon continued service.
• The stock options will vest in full upon the consummation of a Change in Control as defined in the 2020 Incentive Award Plan.
• The expiration date for the options is May 20, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine stock option grant to a director, which is generally viewed as a positive sign of aligning interests. There are no red flags or negative implications.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The vesting schedule of the stock options extends to May 21, 2027, indicating a long-term commitment from the director.

Industry Context

Stock option grants are a common form of compensation for directors of publicly traded companies, particularly in the biotechnology sector, to align their interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Stock option grants to non-employee directors are a standard practice in the biotech industry.
• The vesting schedule of 1/3 after one year and then monthly installments is a typical vesting arrangement.
• The exercise price is set at the market price on the grant date, which is standard practice.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of shareholders, potentially leading to better corporate governance and decision-making.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates